tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (DE:DUL)
FRANKFURT:DUL
Germany Market

Alnylam Pharma (DUL) Ratios

Compare
1 Followers

Alnylam Pharma Ratios

DE:DUL's free cash flow for Q4 2024 was $0.83. For the 2024 fiscal year, DE:DUL's free cash flow was decreased by $ and operating cash flow was $-0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.78 3.08 3.51 2.41 1.91
Quick Ratio
2.71 2.99 3.34 2.31 1.83
Cash Ratio
0.11 0.84 1.13 0.69 0.44
Solvency Ratio
-0.05 -0.10 -0.29 -0.26 -0.34
Operating Cash Flow Ratio
>-0.01 0.11 -0.70 -0.54 -0.55
Short-Term Operating Cash Flow Coverage
0.00 1.89 -13.43 -17.31 -46.18
Net Current Asset Value
$ -877.61M$ -1.07B$ -1.01B$ -186.32M$ -230.99M
Leverage Ratios
Debt-to-Assets Ratio
0.31 0.70 0.37 0.27 0.15
Debt-to-Equity Ratio
19.32 -12.16 -8.34 1.70 0.51
Debt-to-Capital Ratio
0.95 1.09 1.14 0.63 0.34
Long-Term Debt-to-Capital Ratio
0.00 1.10 1.07 0.76 0.16
Financial Leverage Ratio
63.20 -17.36 -22.41 6.19 3.35
Debt Service Coverage Ratio
-1.96 -1.50 -4.74 -3.68 -7.56
Interest Coverage Ratio
-1.25 -2.33 -5.03 -4.95 -9.80
Debt to Market Cap
0.00 0.10 0.08 0.09 0.01
Interest Debt Per Share
11.18 22.45 12.13 9.63 5.27
Net Debt to EBITDA
-6.54 -7.24 -0.49 -0.27 -0.03
Profitability Margins
Gross Profit Margin
85.62%83.02%83.73%83.40%84.16%
EBIT Margin
-10.48%-17.08%-93.60%-83.99%-156.46%
EBITDA Margin
-7.95%-14.12%-89.31%-78.36%-149.40%
Operating Profit Margin
-7.87%-15.43%-75.68%-83.93%-168.09%
Pretax Profit Margin
-7.96%-23.71%-108.63%-100.93%-173.60%
Net Profit Margin
-12.37%-24.08%-109.04%-101.01%-174.15%
Continuous Operations Profit Margin
-12.37%-24.08%-109.04%-101.01%-174.15%
Net Income Per EBT
155.45%101.55%100.37%100.08%100.31%
EBT Per EBIT
101.16%153.63%143.55%120.25%103.28%
Return on Assets (ROA)
-6.56%-11.49%-31.90%-23.41%-25.19%
Return on Equity (ROE)
-414.62%199.53%714.91%-144.99%-84.46%
Return on Capital Employed (ROCE)
-5.79%-9.86%-28.26%-28.90%-36.35%
Return on Invested Capital (ROIC)
-8.88%-9.69%-27.54%-28.04%-35.68%
Return on Tangible Assets
-6.56%-14.06%-34.47%-23.41%-25.19%
Earnings Yield
-0.92%-1.84%-3.91%-4.25%-5.74%
Efficiency Ratios
Receivables Turnover
5.55 5.58 4.36 4.25 4.81
Payables Turnover
3.66 5.59 1.72 1.91 1.50
Inventory Turnover
4.12 3.48 1.31 1.14 0.85
Fixed Asset Turnover
3.24 2.52 1.40 1.15 0.70
Asset Turnover
0.53 0.48 0.29 0.23 0.14
Working Capital Turnover Ratio
1.09 0.93 0.58 0.62 0.54
Cash Conversion Cycle
54.62 104.98 150.46 214.18 264.47
Days of Sales Outstanding
65.80 65.44 83.72 85.85 75.85
Days of Inventory Outstanding
88.62 104.82 278.83 319.57 431.64
Days of Payables Outstanding
99.80 65.28 212.09 191.24 243.01
Operating Cycle
154.42 170.26 362.55 405.42 507.48
Cash Flow Ratios
Operating Cash Flow Per Share
-0.06 0.83 -4.45 -5.42 -5.35
Free Cash Flow Per Share
-0.33 0.34 -5.04 -6.06 -5.96
CapEx Per Share
0.27 0.50 0.59 0.64 0.61
Free Cash Flow to Operating Cash Flow
5.12 0.40 1.13 1.12 1.11
Dividend Paid and CapEx Coverage Ratio
-0.24 1.67 -7.51 -8.40 -8.74
Capital Expenditure Coverage Ratio
-0.24 1.67 -7.51 -8.40 -8.74
Operating Cash Flow Coverage Ratio
>-0.01 0.04 -0.41 -0.64 -1.18
Operating Cash Flow to Sales Ratio
>-0.01 0.06 -0.52 -0.76 -1.25
Free Cash Flow Yield
-0.14%0.18%-2.12%-3.57%-4.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-108.78 -54.31 -25.57 -23.55 -17.41
Price-to-Sales (P/S) Ratio
13.46 13.08 27.88 23.79 30.32
Price-to-Book (P/B) Ratio
451.03 -108.36 -182.78 34.15 14.71
Price-to-Free Cash Flow (P/FCF) Ratio
-710.48 569.99 -47.15 -27.97 -21.81
Price-to-Operating Cash Flow Ratio
-3.64K 229.54 -53.43 -31.30 -24.30
Price-to-Earnings Growth (PEG) Ratio
2.82 0.87 -0.88 6.76 2.17
Price-to-Fair Value
451.03 -108.36 -182.78 34.15 14.71
Enterprise Value Multiple
-175.72 -99.82 -31.70 -30.63 -20.33
EV to EBITDA
-175.72 -99.82 -31.70 -30.63 -20.33
EV to Sales
13.98 14.10 28.31 24.00 30.37
EV to Free Cash Flow
-737.92 614.57 -47.89 -28.22 -21.84
EV to Operating Cash Flow
-3.78K 247.50 -54.27 -31.58 -24.34
Tangible Book Value Per Share
0.52 -7.35 -3.47 4.97 8.84
Shareholders’ Equity Per Share
0.52 -1.77 -1.30 4.97 8.84
Tax and Other Ratios
Effective Tax Rate
-0.55 -0.02 >-0.01 >-0.01 >-0.01
Revenue Per Share
17.48 14.64 8.53 7.13 4.29
Net Income Per Share
-2.16 -3.52 -9.30 -7.20 -7.46
Tax Burden
1.55 1.02 1.00 1.00 1.00
Interest Burden
0.76 1.39 1.16 1.20 1.11
Research & Development to Revenue
0.50 0.55 0.85 0.94 1.33
SG&A to Revenue
0.43 0.44 0.74 0.74 1.19
Stock-Based Compensation to Revenue
0.12 0.12 0.22 0.20 0.28
Income Quality
0.03 -0.24 0.48 0.75 0.72
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis